Articles, App Notes, Case Studies, & White Papers

1. Integrating Early-Phase Clinical Supply Manufacturing & Distribution 5/10/2022

   A tablet formulation was a solution when developing a new class of anti-infective medicine, allowing the integration of formulation development, clinical trial material (CTM) manufacturing, and supply and distribution to patients.

2. Making The Right Choice For Multiparticulate Modified Release Dosage Forms 4/2/2021

   Wurster processing is a versatile pharmaceutical development and manufacturing technique for multiparticulates in modified release dosage forms. Understand if it's the right method for your modified-release project.

3. A Guide To Optimize Analytical Strategies Throughout The Biologics Development Life Cycle

   A miscalculated analytical approach can be costly to develop, perform, and maintain. Many organizations also lack appropriate resources to create optimal testing methods and protocols.

4. Snapshot Of The Parenteral Drug Delivery Market 6/17/2022

   Growth in the development of parenteral drugs is driving demand for advanced drug delivery devices such as prefilled syringes, autoinjectors, and pen-injectors, growing segments in fill-finish manufacturing.

5. How To Protect A Modern Silicone Oil-Sensitive Biologic Drug For Self-Injection Of 2.25mL 4/25/2023

   A customer experienced expensive project delays when they selected their “tried and tested” large volume, glass syringe system to package a drug to be used in an auto-injector for self-administration.

6. Sophisticated Formulation Approaches For Insoluble Drug Candidates 1/24/2022

   A sophisticated drug delivery approach involves collaboration, technical experience, and years of working knowledge in drug development at different stages of the process.

7. Overcoming Limitations To Achieve Uniform Dosing 1/24/2022

   An immediate need for lower dose capsules in the clinic posed several challenges in blend formulation with very tight timelines for delivery.

8. Selecting Drug Delivery Systems For Higher Doses, Viscosities And Lower Risk 1/18/2022

   Discover how companies can de-risk their device selection as they bring this new generation of high-volume, high-viscosity biologics to market.

9. Integrated Strategies for Achieving Regulatory Milestones Faster 10/12/2023

   Learn how an innovative formulation platform reduced development timelines and allowed a sponsor to find the optimal nafamostat formulation without adding unnecessary delays.

10. Single Source Partner: Seamless Approach To Deliver World-Class Treatment 5/5/2022

    Growing demand for high-value, complex therapies requires the right containment and delivery systems: solutions that offer superior quality and patient comfort while meeting stringent regulatory requirements.